MK-733

Known as: MK 733, MK733 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-1992
024619861992

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
The effect of simvastatin (MK-733), a potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on the… (More)
Is this relevant?
1991
1991
The effect of simvastatin (MK-733), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on plasma… (More)
Is this relevant?
1990
1990
A new antihypercholesterolemic drug, simvastatin (MK-733), which is a prodrug of a potent 3-hydroxy-3-methylglutaryl coenzyme A… (More)
Is this relevant?
1989
1989
The effects of simvastatin (MK-733), a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on serum lipids… (More)
Is this relevant?
1989
1989
MK-733 was found to prevent an increase of serum cholesterol levels in cholesterol-fed rabbits, and lovastatin also markedly… (More)
Is this relevant?
1989
1989
MK-733 (simvastatin), a potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, was found to inhibit the… (More)
Is this relevant?
1988
1988
Simvastatin (MK-733), a new inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, was administered to 38 patients with… (More)
Is this relevant?
1988
1988
Effects of MK-733 on the absorption and excretion of cholesterol in rabbits were examined using [3H]cholesterol. The animals were… (More)
Is this relevant?
1987
1987
MK-733, which is a competitive inhibitor of the rate-limiting step in cholesterol biosynthesis, or a matching placebo was… (More)
Is this relevant?
1986
1986
The effects of synvinolin (MK-733), a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, were investigated… (More)
Is this relevant?